Organisation paid for research Program year 2021 Source: CMS Open Payments

Capstone Clinical Research Incorporated

Neither a doctor nor a teaching hospital

Research payments

$351,156

48 payments

Through program year 2021, Capstone Clinical Research Incorporated is reported as receiving $351,156 in research payments, across 48 payments.

By program year

3 rows

Year	Kind	Amount	Payments
2021	Research	$112,430	8
2020	Research	$92,229	12
2019	Research	$146,496	28

Breakdown

Who paid Research payments · program years 2019–2021

Allergan Inc. $351,156 48 payments

Studies the money was for Research payments · program years 2019–2021

Phase 4 (PMR Pediatric Gad) $109,820 6 payments
Phase 4 (PMR Pediatric Gad) $92,229 12 payments
Lvm-MD-14 Preapmrphase 3Double-Blind $53,342 12 payments
Phase 4 PMR Pediatric GAD $43,392 5 payments
A Randomized, Double-Blind, Placebo Controlled, Multicenter Study of Rapastinel As Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder $30,225 5 payments
An Open Label, Long Term Safety Study of Rapastinel As An Adjunctive Therapy in Patients With Major Depressive Disorder MDD. $5,038 1 payment
An Open Label, Long Term-Extended Access Protocol for Rapastinel As Adjunctive Or Monotherapy Treatment in Patients With Mayor Depressive Disorder $5,000 1 payment
A Multicenter, Double Blind, Placebo and Active-Controlled Parallel-Group Evaluation of the Safety and Efficacy of Vilazodone in Pediatric Patients With Major Depressive Disorder $4,034 2 payments
A Double-Blind, Placebo-Controlled Study of Cariprazine As Adjunctive Therapy in Major Depressive Disorder $3,506 1 payment
Lvm-MD-14 (Prea/Pmr/Phase 3/Double-Blind) $2,160 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.